These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38972928)

  • 1. ASO Visual Abstract: To Revise or Not to Revise? Isolated Margin Positivity in Localized Pancreatic Ductal Adenocarcinoma.
    Elshami M; Wu VS; Stitzel HJ; Hue JJ; Loftus AW; Kyasaram RK; Shanahan J; Ammori JB; Hardacre JM; Ocuin LM
    Ann Surg Oncol; 2024 Jul; ():. PubMed ID: 38972928
    [No Abstract]   [Full Text] [Related]  

  • 2. To Revise or Not Revise? Isolated Margin Positivity in Localized Pancreatic Ductal Adenocarcinoma.
    Elshami M; Wu VS; Stitzel HJ; Hue JJ; Loftus AW; Kyasaram RK; Shanahan J; Ammori JB; Hardacre JM; Ocuin LM
    Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38896228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASO Author Reflections: Isolated Margin Positivity in Localized Pancreatic Ductal Adenocarcinoma and Operative Margin Revision.
    Elshami M; Ocuin LM
    Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38907137
    [No Abstract]   [Full Text] [Related]  

  • 4. Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal adenocarcinoma.
    Katou S; Wenning AS; Aeschbacher P; Morgul H; Becker F; Pascher A; Gloor B; Strücker B; Andreou A
    Surgery; 2023 Jul; 174(1):91-99. PubMed ID: 37121858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review.
    Datta J; Willobee BA; Ryon EL; Shah MM; Drebin JA; Kooby DA; Merchant NB
    JAMA Surg; 2021 May; 156(5):489-495. PubMed ID: 33533898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.
    Gonzalez RS; Bagci P; Basturk O; Reid MD; Balci S; Knight JH; Kong SY; Memis B; Jang KT; Ohike N; Tajiri T; Bandyopadhyay S; Krasinskas AM; Kim GE; Cheng JD; Adsay NV
    Mod Pathol; 2016 Nov; 29(11):1358-1369. PubMed ID: 27469329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition".
    Belfiori G; Crippa S; Pagnanelli M; Gasparini G; Aleotti F; Camisa PR; Partelli S; Pecorelli N; De Stefano F; Lena MS; Palumbo D; Tamburrino D; Reni M; Falconi M
    Ann Surg Oncol; 2024 Jun; 31(6):4119-4120. PubMed ID: 38528177
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Margin-Positive Pancreatic Ductal Adenocarcinoma During Pancreaticoduodenectomy: Additional Resection Does Not Improve Survival.
    Zheng R; Nauheim D; Bassig J; Chadwick M; Schultz CW; Krampitz G; Lavu H; Winter JR; Yeo CJ; Berger AC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):895-896. PubMed ID: 32813199
    [No Abstract]   [Full Text] [Related]  

  • 9. In the Era of the Leeds Protocol: A Systematic Review and A Meta-Analysis on the Effect of Resection Margins on Survival Among Pancreatic Ductal Adenocarcinoma Patients.
    Kurlinkus B; Ahola R; Zwart E; Halimi A; Yilmaz BS; Ceyhan GO; Laukkarinen J
    Scand J Surg; 2020 Mar; 109(1):11-17. PubMed ID: 32192417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASO Visual Abstract: Predictors for Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.
    Javed AA; Mahmud O; Fatimi AS; Habib A; Grewal M; He J; Wolfgang CL; Besselink MG;
    Ann Surg Oncol; 2024 May; ():. PubMed ID: 38819749
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Visual Abstract: Skeletal Muscle-Derived Irisin Enhances Gemcitabine Sensitivity and Suppresses Migration Ability in Pancreatic Ductal Adenocarcinoma.
    Sugimoto T; Iwagami Y; Kobayashi S; Yamanaka C; Sasaki K; Yamada D; Tomimaru Y; Asaoka T; Noda T; Takahashi H; Shimizu J; Doki Y; Eguchi H
    Ann Surg Oncol; 2024 May; ():. PubMed ID: 38702394
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
    Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
    J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
    Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
    Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
    Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
    World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.
    Kooby DA; Lad NL; Squires MH; Maithel SK; Sarmiento JM; Staley CA; Adsay NV; El-Rayes BF; Weber SM; Winslow ER; Cho CS; Zavala KA; Bentrem DJ; Knab M; Ahmad SA; Abbott DE; Sutton JM; Kim HJ; Yeh JJ; Aufforth R; Scoggins CR; Martin RC; Parikh AA; Robinson J; Hashim YM; Fields RC; Hawkins WG; Merchant NB
    Ann Surg; 2014 Sep; 260(3):494-501; discussion 501-3. PubMed ID: 25115425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical study about applying different R1 criteria to evaluate pancreatic head ductal adenocarcinoma specimens].
    Peng Y; Xiu D; Jiang B; Ma Z; Yuan C; Su J; Shi X; Li L; Tao M
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):834-8. PubMed ID: 25604022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma.
    Jamieson NB; Foulis AK; Oien KA; Going JJ; Glen P; Dickson EJ; Imrie CW; McKay CJ; Carter R
    Ann Surg; 2010 Jun; 251(6):1003-10. PubMed ID: 20485150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
    Kelly KN; Macedo FI; Seaton M; Wilson G; Hammill C; Martin RC; Maduekwe UN; Kim HJ; Maithel SK; Abbott DE; Ahmad SA; Kooby DA; Merchant NB; Datta J
    Ann Surg Oncol; 2022 Sep; 29(9):6004-6012. PubMed ID: 35511392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Path to Whipple Reconstruction for Pancreatic Adenocarcinoma: Trans-Mesocolon or Through Ligament of Treitz?
    Gamboa AC; Zaidi MY; Lee RM; Sarmiento JM; Kooby DA; Russell MC; Cardona K; Maithel SK
    J Gastrointest Surg; 2020 Sep; 24(9):2046-2053. PubMed ID: 31468334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of transmembrane serine protease 4 on the survival in patients with pancreatic ductal adenocarcinoma undergoing surgery followed by adjuvant chemotherapy.
    Tazuma S; Sudo T; Ishikawa A; Yamaguchi A; Shibata Y; Ishida Y; Kuraoka K; Uemura K; Takahashi S; Tashiro H
    Surg Today; 2024 Apr; ():. PubMed ID: 38637344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.